STAT+: Bladder cancer immunotherapy from CG Oncology reduced risk of tumor recurrence
🌐 Source: Statnews • 📅 16 Nov 2026 • ⏱️ 1 min read (23 words, ⚡ Quick Read)
STAT Plus: Versant, Lilly put $100 million behind new startup aimed at solving one of gene therapy’s thorniest issues
→ Read original article